Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi Dear, why made you so confident about AVAX?
HI Dear, Any comments on AVAX?
Hi Dear, have you already invested AVAX?
Do whatever you like; sell/ add/ do nothing at all, etc. One thing's for certain; the price isn't just being moved up and down; AVXT is being accumulated!
Also ... All the sales/buys on the OTC. My opinion is it's just an MM playing the market. Moving the price up and down.
Could be..... but got my doubts as to it being AVXT. From a business point of view. If it were AVXT, they would be tooting their horn big time.
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer:
Is it AVAX ???
Science Translational Medicine 11 Apr 2018:
1) Janos L. Tanyi
Ovarian cancer research center
Abramson Cancer Center, Perelman School of Medicine,
University of Pennsylvania, Philadephia, PA 19104, USA
6) Drew A. Torigian - Harvey L. Nisenbau ... Philadephia, PA 19104, USA
7) Carl H. June - Bruce L. Levine ... Philadephia, PA 19104, USA
8) Rosemarie Mick ... Philadephia, PA 19104, USA
SOURCE: http://stm.sciencemag.org/content/10/436/eaao5931
Full text without login:
https://drive.google.com/open?id=1cQeb_Ev-nEnfdPoRqGPpkPpPQt75bpYI
Too bad they no longer have a web site, or a phone no. They're broke and if they're still in business it's news to me.
Immunotherapies represent the new wave in Cancer treatments.... $AVXT is going to be huge!
http://www.bbc.com/news/health-36549674
Cancer vaccine's are garnering a lot of attention these days! I'm including a link to a Stanford study I believe is relevant to AVXT's on going trials.
https://med.stanford.edu/news/all-news/2018/01/cancer-vaccine-eliminates-tumors-in-mice.html
Well, Geoman, maybe there is a glimmer of hope for us very, very longs in this.
A new report that came out on January 10th 2018,about melanoma vaccines key market players still lists AVAX as one them. Here's the link:
http://www.ktre.com/story/37241244/melanoma-global-market-2017-key-players-ab-science-amgen-array-biopharma-avax-technologies-and-more
Why would they include Avax on the list if it's dead for all intents and purposes? I think their strongest points against the big competitors are the statistically high survival rate and almost no side effects. Their weakest is not capitalizing on that. Good doctors and researchers do not always make good business people and it shows.
Just saying, cause otherwise we get nothing from the company.
I notice the MM's still manipulating this thing. Problemis if "you" bought at say .00? and it went up - you would never be able to unload.
Got the same when I went to the website. Yet the MM's keep playing this game with buying and selling each day causing the stock to rise and fall while laughing at us fools. Fool is the word....100 G's gone and a long wait to nowhere...20 years coming one month away...mistake of a lifetime....and yet we have those who think this is funny and keep buying this and bragging about it....do not need to hear from false profits on this (get the pun?)..profits? but welcome any true good news not.. Gee...I got a feeling crap....
I got out a long time ago but I kept checking things out once and a while.
Well Geoman,
Went to AVXT's web page - Got a blank screen the first time and then got a screen wanting to know if I wanted to buy the domain. Then I tried to phone them - got a tape recorded message asking is I wanted this or that Pharmacy - press 1 or 2 or 3, etc.
Looks like they are in full belly up mode now. Only MM games going on on the stock exchanges. Just my opinion.
PS...come January, it will be 20 years that I have been with this company...20 years....Get the picture?
This is not a game. If you have some hard facts then release them. If you are just basing it on inexperienced emotions, do us a favor and keep them to yourself. Tell us what platform you are making these assumptions on either fact or fiction!. I don't need false hopes after I lost 100 grand on this company....not at my age. I can't find any current info on AVXT and it has been 2 years and 3 months since we heard anything from the company. So either put up and help us all or shut up! False emotional crap does not help any of us in this sinking boat.....Geo....
Please, have you a link?
Or, is it just your feeling?
It's a beautiful day here in AVXT land! The MM's won't be able to hold this down for much longer; word is getting out. The treatment protocol works.
When you only have $250.00 left after putting 100 grand into this company....why pay attention? We have heard nothing in two years....nothing...I have watched my retirement dribble away as they ate it up and ran for the hills....
Level II CSTI .2540
CANT .5040
Is anyone else here paying attention?
Someone just sold 166 shares at .002.... LMAO! They made a whopping 33 cents and probably spent 8 bucks to execute the trade. Nice!
The website sometimes appears completely white and sometimes with 6 points, as it is indicated below.
From each point you access new pages with five new points that lead to strange links (I believe test links)...
- Cancer Research
- Biotechnology Company
- Cancer Vaccines
- Metastatic Melanoma
- Therapeutic Treatment
- Pharmaceutical Company
- Drug Development
I bought AVAX shares in 2010, then a slow decline in value per share, today I just hope to recover the capital invested 7 years ago!
However if we suddenly get a news from the FDA, I'd be happy to see the stock over $ 1 per share.
-----------------------------------------------------------
Anyway, I would appreciate your comment related to:
- Lack of money
- Trials stopped for a long time
- Absence of management
- Bankruptcy that everyone waited and never arrived.
.
Ha! That's great news; thanks for updating us!.
I've been trading this company for the past 6 years and I've done a lot of DD...... Simply put their treatment has been proven to be incredibly effective. Just look at the last info on the clinical trials from January 2016. CTCA continues to use treat their patients with the vaccine protocol. Why treat patients with something that doesn't work?
The OTC is a brutal place to trade stocks and there's a ton of manipulation going on here for sure, but I'm not losing sight of the goal. Let the MM's play their games... I know what I own!
GL
News !
The web designer is working tonight on new Avax website...
I think you have nose for business like a hound dog ... or you have sensitive crystal ball …
.
How can you be so optimistic?
No updates since some years, trials has been stopped since long time, white web site, without money and without lenders ...
Are you a pumper or do you have confidential information?
.
I would like to give a big thank you to the person who just sold me 100k shares at .0020!!!
I'm not sure what's going on with the website; however there are positive signs we are on the move up. ETRF has raised their ask to .04 and CDEL is at .05. Just 130k shares separate .004 from .04... CSTI has been flirting with an ask of .25!
I just got the same result.
AVAX website is disappeared ...
http://www.avax-tech.com/
Whois Search Results:
https://reports.internic.net/cgi/whois?whois_nic=avax-tech.com&type=domain
.
Level II is incredibly thin... After we clear the 45's, 95, 97, .05!
This is looking real good! Slapping that ASK!
CDEL is now on the ask at 4 cents per share!
Thanks to whomever just sold me 101,688 shares at .0015!!!
Nice ask slapping at for 225k @ .004 to start the day!
Has anyone noticed CSTI parked at .25?
Silent treatment ha.... Lol. Believe me I've suffered mightily with this stock for the past 6 years; I'm down tens of thousands. However I remain optimistic and believe something's cooking in that there kitchen; MM's took this down hard trading no shares of their own. They've been scooping up anything and everything anyone's willing to part with.
We've been due clinical trials updates for a very long time now and I have the distinct feeling positive news is on it's way. The data from the last phase was incredible, so I have to think that this time around it's going to be epic! Or not..... Either way I'm accumulating.
Nice pick up of 100k more shares this morning @.0015!!! Keep the cheapies coming!
Level two looking solid; next leg up is .004!
It's ASK SLAPPING TIME!!! $AVTX...
Looks like the hole has been dug in the graveyard. Just have to drop in the coffin & backfill.
Crooks?
Just my opinion.
How could they allow 20 years of research to just slip away???? I believed so much in these guys....why? They just took my 100 Gs and spent it on their own salaries....this still hurts so badly....The USA...where white collar crime is just overlooked day after day because our administrators are part of that system...
All that is going on is someone (MM?) selling/buying back and forth to make a few bucks.
Is anyone still alive or has this crapper killed us all...?
Unfortunately on link there are old data, the CEO had resigned long ago and AVAX is a ship adrift without a captain, no fuel, no food, ...
I thought CTCA http://www.cancercenter.com/ wanted possession of AVAX and complete the trial of O-vax and M-vax. Or sales of patents to other Pharmaceutical Companies.
Last year, I sent email to many Big Pharma to demonstrate the great potential to acquire AVAX for low price, or to enter into partnership.
My hope is that something is happening behind the scenes ...
Maybe someone is trying to buy shares gradually (average of about 200 thousand per day) to avoid the sudden rise in price ...
I'm waiting for the miracle of President Trump to eliminate the FDA bureaucracy!
AVAX on hands of an astute businessman could reach $5 in one night ...
https://www.nytimes.com/2017/02/05/health/with-fda-vacancy-trump-sees-chance-to-speed-drugs-to-the-market.html?_r=0
.
Unfortunately on link there are old data, the CEO had resigned long ago and AVAX is a ship adrift without a captain, no fuel, no food, ...
I thought CTCA www.cancercenter.com/ wanted possession of AVAX and complete the trial of O-vax and M-vax. Or sales of patents to other Pharmaceutical Companies.
Last year, I sent email to many Big Pharma to demonstrate the great potential to acquire AVAX for low price, or to enter into partnership.
My hope is that something is happening behind the scenes ...
Maybe someone is trying to buy shares gradually (average of about 200 thousand per day) to avoid the sudden rise in price ...
I'm waiting for the miracle of President Trump to eliminate the FDA bureaucracy!
AVAX on hands of an astute businessman could reach $5 in one night ...
https://www.nytimes.com/2017/02/05/health/with-fda-vacancy-trump-sees-chance-to-speed-drugs-to-the-market.html?_r=0
.
Followers
|
34
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1605
|
Created
|
05/25/05
|
Type
|
Free
|
Moderators |
Industry Center - Biotechnology
Contact Information | |
Address: | 2000 Hamilton St., Ste. 204 Philadelphia, PA 19130 |
Phone: | 215-241-9760 |
Fax: | 215-241-9684 |
Key People | |
• | CEO: Adele Sommerfeld |
• | BOD: Andrew W. Dahl Sc.D.; Serge Morrell |
| |||
|
Business Summary |
---|
AVAX Technologies, Inc., a development stage biotechnology company, together with its subsidiaries, engages in the development and future commercialization of individualized vaccine therapies and other technologies for the treatment of cancer in the United States and Europe. The company's autologous cell vaccine candidates include M-Vax under Phase III clinical status, which is used for the treatment of melanoma; L-Vax under Phase I-II clinical status that is used for the treatment of non-small cell lung cancer; and O-Vax under Phase I-II clinical status, which is used for the treatment of ovarian cancer. It also offers biological manufacturing services to other biotechnology and pharmaceutical companies; and contract manufacturing services in for cell and gene therapy, and biological products in France. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.
PHILADELPHIA, Feb. 4, 2011 /PRNewswire/ -- AVAX Technologies, Inc. (Pink Sheets:AVXT.pk - News) ("AVAX" or the "Company") today announced that it filed a Form 10 with the Securities and Exchange Commission ("SEC"). Upon the effectiveness of this Form 10, AVAX will once again become a publicly reporting company. The Company intends to seek to have its common stock trade on the Over-the-Counter Bulletin Board.
The Company's Form 10, which contains among other things, recent information about the Company's business, operations, financial results and capitalization, can be accessed through the website maintained by the SEC at www.sec.gov.
About AVAX Technologies, Inc.
AVAX Technologies, Inc. is a biotechnology company headquartered in Philadelphia, PA. The Company is engaged in the research and clinical and commercial development of biological products and cancer therapeutics.
The Company's AC Vaccine platform is a therapeutic cancer vaccine.
Forward-Looking Statements
Certain statements in this release are "forward-looking" statements. Forward-looking statements involve significant risks and uncertainties, and in light of the significant uncertainties inherent in such statements, the inclusion of such information should not be regarded as a representation by the Company that the objectives and plans of the Company will be achieved. In fact, actual results could differ materially from those contemplated by such forward-looking statements. These statements include, but are not limited to, the Company's immediate need to obtain additional funding to continue to finance the Company, the Company's plans, objectives, projections, expectations and intentions such as those relating to the future development of M-VAX® and its other vaccine candidates, as well as other important factors discussed in the Company's Form 10. The Company does not undertake any obligation to release publicly any revisions to these forward-looking statements or to reflect the occurrence of unanticipated events.
Press Releases & AVAX Information:
https://en.wikipedia.org/wiki/Avax_Technologies
http://www.reuters.com/article/2014/01/08/ctca-trial-cancer-idUSnPnDChVKwJ+16d+PRN20140108
http://ih.advfn.com/p.php?pid=nmona&article=61013370
http://www.bizjournals.com/philadelphia/blog/health-care/2014/02/ovarian-cancer-vaccine-testing-expands.html
http://www.avax-tech.com/about/pdfs/avaxfactsheet.pdf
Published: Aug 4, 2015 7:31 p.m. ET
PHILADELPHIA, Aug 04, 2015 (BUSINESS WIRE) -- AVAX Technologies, Inc., (“AVAX” or “The Company”) (AVXT – OTCMKTS), a leading developer of proprietary cancer immunotherapy products, has signed a Settlement & Release Agreement with Cancer Treatment Centers of America Inc. (“CTCA”) to positively resolve the existing debt obligations owed to CTCA.
Under the terms of the Settlement Agreement, CTCA has agreed to settle its $5,826,464.73 Judgment against AVAX in exchange for 860,000 Series A Convertible Preferred Shares at a consideration of $5.00 per share, and a one-time payment of $1.5 million in cash. Firebird Management, a shareholder and a creditor of AVAX, has agreed to swap its outstanding debt for the Series A Convertible Preferred Shares also at a consideration of $5.00 per share.
Andrew Dahl, AVAX Board Member noted, “we are extremely happy to be able to move forward with the reorganization of AVAX’s balance sheet and look forward to re-commencing the important planned clinical trials at AVAX. Our previous work with CTCA on clinical programs has been very successful.”
Richard Rainey, Acting Chief Executive Officer of AVAX, stated, “We are pleased that throughout the development of our AC Vaccine® platform, all of our data has remained consistently positive and has supported further development of the treatment. We feel our immunotherapy platform is consistent with recently approved products and could be additive to the benefits achieved in helping patients with cancer.”
SGC Canada Inc., is acting on behalf of AVAX with its creditors in negotiating its informal restructuring plan. David Holden, the Senior Corporate Advisor of SGC states that “AVAX will be effectively debt-free once the Financial Restructuring & Refinancing Plan is completed.” The Board of AVAX has previously approved the engagement of Phoenix Corporate Finance Inc., a corporate finance firm which specializes in alternative financing, to advise, structure, and facilitate the distribution of a proposed Private Placement financing. through select securities dealers in the US and Canada. AVAX intends to raise $45 million to fund its next round of clinical testing through the issuance of the Series A Convertible Preferred Shares.
AVAX TECHNOLOGIES WEBSITE IS NOW ACTIVE: WWW.AVAX-TECH.COM/
AVAX TECHNOLOGIES, INC APPOINTS NEW CEO: ADELE SOMMERFELD 10/19/2015
http://www.prnewswire.com/news-releases/avax-technologies-inc-announces-the-appointment-of-chief-executive-officer-300161646.html
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |